Here a link to another article on tailoring BC chemo and relation to HER 2.
I know very little about chemo. There is some comment on HER 2 alternatives at the end. I suspect it is another take on Lani's news item above.
RB
http://www.medpagetoday.com/Hematolo...Cancer/tb/3319
ABSTRACT
MedPage Today Action Points
* Explain to interested patients that a tumor's HER2 status is increasingly important for treatment decisions.
* In particular, note that this study suggests that women without HER2 over-expression can be treated with a less-aggressive form of adjuvant chemotherapy.
* Note that the trial described here reflects treatment before the availability of Herceptin (trastuzumab) for HER2-positive breast tumors.